CH677925A5 - - Google Patents

Download PDF

Info

Publication number
CH677925A5
CH677925A5 CH4607/87A CH460787A CH677925A5 CH 677925 A5 CH677925 A5 CH 677925A5 CH 4607/87 A CH4607/87 A CH 4607/87A CH 460787 A CH460787 A CH 460787A CH 677925 A5 CH677925 A5 CH 677925A5
Authority
CH
Switzerland
Prior art keywords
compounds
formula
acid addition
addition salts
phenyl
Prior art date
Application number
CH4607/87A
Other languages
German (de)
English (en)
Inventor
Helmut Dr Egger
Rudolf Dr Waelchli
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH677925A5 publication Critical patent/CH677925A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH4607/87A 1986-12-03 1987-11-26 CH677925A5 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (1)

Publication Number Publication Date
CH677925A5 true CH677925A5 (uk) 1991-07-15

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4607/87A CH677925A5 (uk) 1986-12-03 1987-11-26

Country Status (24)

Country Link
JP (1) JPH0678318B2 (uk)
KR (1) KR880007481A (uk)
AT (1) AT395587B (uk)
AU (1) AU605522B2 (uk)
BE (1) BE1001235A4 (uk)
CH (1) CH677925A5 (uk)
DK (1) DK631287A (uk)
ES (1) ES2010235A6 (uk)
FI (1) FI875300A (uk)
FR (1) FR2607810B1 (uk)
GB (1) GB2199579B (uk)
GR (1) GR871897B (uk)
HU (1) HU198694B (uk)
IL (1) IL84665A (uk)
IT (1) IT1211944B (uk)
LU (1) LU87063A1 (uk)
MY (1) MY103004A (uk)
NL (1) NL8702897A (uk)
NZ (1) NZ222765A (uk)
PH (1) PH24666A (uk)
PL (1) PL151588B1 (uk)
PT (1) PT86255B (uk)
SE (1) SE8704792L (uk)
ZA (1) ZA879093B (uk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
RO114129B1 (ro) * 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法

Also Published As

Publication number Publication date
PL269180A1 (en) 1988-08-18
DK631287D0 (da) 1987-12-01
FI875300A (fi) 1988-06-04
NZ222765A (en) 1990-11-27
LU87063A1 (fr) 1988-07-14
ES2010235A6 (es) 1989-11-01
IT1211944B (it) 1989-11-08
PL151588B1 (en) 1990-09-28
BE1001235A4 (fr) 1989-08-29
FR2607810B1 (fr) 1989-12-01
GB8727978D0 (en) 1988-01-06
NL8702897A (nl) 1988-07-01
SE8704792D0 (sv) 1987-12-01
SE8704792L (sv) 1988-06-04
ZA879093B (en) 1989-07-26
IL84665A0 (en) 1988-05-31
AU605522B2 (en) 1991-01-17
ATA316887A (de) 1992-06-15
PH24666A (en) 1990-09-07
KR880007481A (ko) 1988-08-27
HUT45506A (en) 1988-07-28
GR871897B (en) 1988-04-04
JPS63145270A (ja) 1988-06-17
PT86255B (pt) 1990-11-07
FI875300A0 (fi) 1987-12-01
FR2607810A1 (fr) 1988-06-10
JPH0678318B2 (ja) 1994-10-05
GB2199579B (en) 1990-07-18
AU8196287A (en) 1988-06-16
MY103004A (en) 1993-03-31
HU198694B (en) 1989-11-28
IT8748656A0 (it) 1987-12-01
GB2199579A (en) 1988-07-13
IL84665A (en) 1991-11-21
PT86255A (en) 1988-06-01
AT395587B (de) 1993-01-25
DK631287A (da) 1988-06-04

Similar Documents

Publication Publication Date Title
DE3218584C2 (uk)
EP0770613A1 (de) Substituierte Imidazolidin-2,4-dion-Verbindungen als Immunodulatore
US4304782A (en) Psychotropic deuterated derivatives of phenylhydantoin and pharmaceutical compositions comprising such derivatives
DE69828999T2 (de) 1-(4-(1-(4-fluorophenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-pperidin)-hydrohalogenide
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
EP0304534A1 (de) Dihydropyridazinon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT395587B (de) Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate
US3947475A (en) 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
EP0411735A1 (de) Cycloakylenazole, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese enthalten sowie ihre Verwendung zur Herstellung von Arzneimitteln
DE1470284B1 (de) Beta-{1-Methyl-4-[1-methyl-4-(1-methyl-4-formylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido]-pyrrol-2-carboxamido}-propionamidin sowie dessen Saeureadditionssalze
EP0283857A1 (de) Benzylidenamino-, benzylamino- und benzoylamino-imidazolderivate
DE3438244C2 (uk)
DE3740125A1 (de) Azolderivate
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2917890C2 (uk)
DE2148552A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
DE3129719C2 (de) Pharmazeutisches Mittel
DE2614137C2 (de) Benzo[b]thien(2)-ylaminoäthylketone, Verfahren zu ihrer Herstellung, sowie diese enthaltende Arzneimittel
DE1468681C3 (de) 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel
EP0004261B1 (de) Neue Imidazolderivate, Verfahren zu deren Herstellung und Arzneimittel diese enthaltend
DE1470284C (de) beta- geschweifte Klammer auf 1-Methyl-4- eckige Klammer auf l-methyl-4-(l-methyl-4-fonnylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido eckige Klammer zu -pyrrol-2carboxamido geschweifte Klammer zu -propionamidin sowie dessen Säureadditionssalze
CH615181A5 (en) Process for the preparation of novel ergolene derivatives
CH640235A5 (de) 8-beta-hydrazinomethyl-ergolinderivate und verfahren zu ihrer herstellung.
DE2031238C3 (de) i.a-Diphenyl-S.S-dioxo^-substituierter Pyrazolidine, Verfahren zu deren Herstellung und Arzneimittel
AT389310B (de) Cyclohexandion-derivat und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
PL Patent ceased